Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.
2.

The potentially beneficial central nervous system activity profile of ivacaftor and its metabolites.

Schneider EK, McQuade RM, Carbone VC, Reyes-Ortega F, Wilson JW, Button B, Saito A, Poole DP, Hoyer D, Li J, Velkov T.

ERJ Open Res. 2018 Mar 13;4(1). pii: 00127-2017. doi: 10.1183/23120541.00127-2017. eCollection 2018 Jan. Erratum in: ERJ Open Res. 2018 Dec 21;4(4):.

3.

A Fresh Shine onCystic Fibrosis Inhalation Therapy: Antimicrobial Synergy of Polymyxin B in Combination with Silver Nanoparticles.

Jasim R, Schneider EK, Han M, Azad MAK, Hussein M, Nowell C, Baker MA, Wang J, Li J, Velkov T.

J Biomed Nanotechnol. 2017 Apr;13(4):447-57.

PMID:
29384621
4.

Using c-Jun to identify fear extinction learning-specific patterns of neural activity that are affected by single prolonged stress.

Knox D, Stanfield BR, Staib JM, David NP, DePietro T, Chamness M, Schneider EK, Keller SM, Lawless C.

Behav Brain Res. 2018 Apr 2;341:189-197. doi: 10.1016/j.bbr.2017.12.037. Epub 2017 Dec 29.

5.

Broad activity of diphenyleneiodonium analogues against Mycobacterium tuberculosis, malaria parasites and bacterial pathogens.

Nguyen N, Wilson DW, Nagalingam G, Triccas JA, Schneider EK, Li J, Velkov T, Baell J.

Eur J Med Chem. 2018 Mar 25;148:507-518. doi: 10.1016/j.ejmech.2017.10.010. Epub 2017 Oct 6.

PMID:
29269132
6.

Magnetic Nanoparticles Coated with a Thermosensitive Polymer with Hyperthermia Properties.

Reyes-Ortega F, Delgado ÁV, Schneider EK, Checa Fernández BL, Iglesias GR.

Polymers (Basel). 2017 Dec 22;10(1). pii: E10. doi: 10.3390/polym10010010.

7.

Rapamycin Confers Neuroprotection against Colistin-Induced Oxidative Stress, Mitochondria Dysfunction, and Apoptosis through the Activation of Autophagy and mTOR/Akt/CREB Signaling Pathways.

Dai C, Ciccotosto GD, Cappai R, Wang Y, Tang S, Hoyer D, Schneider EK, Velkov T, Xiao X.

ACS Chem Neurosci. 2018 Apr 18;9(4):824-837. doi: 10.1021/acschemneuro.7b00323. Epub 2018 Jan 5.

PMID:
29257864
8.

A Portrait of the Sialyl Glycan Receptor Specificity of the H10 Influenza Virus Hemagglutinin-A Picture of an Avian Virus on the Verge of Becoming a Pandemic?

Schneider EK, Li J, Velkov T.

Vaccines (Basel). 2017 Dec 13;5(4). pii: E51. doi: 10.3390/vaccines5040051. Review.

10.

Multi-Component Uptake of Dye Molecules by Films of Nanoporous Metal-Organic Frameworks.

Saghanejhadtehrani M, Schneider EK, Heinke L.

Chemphyschem. 2017 Dec 15;18(24):3548-3552. doi: 10.1002/cphc.201701023. Epub 2017 Nov 15.

PMID:
29072361
11.

Cationic Acrylate Oligomers Comprising Amino Acid Mimic Moieties Demonstrate Improved Antibacterial Killing Efficiency.

Grace JL, Elliott AG, Huang JX, Schneider EK, Truong NP, Cooper MA, Li J, Davis TP, Quinn JF, Velkov T, Whittaker MR.

J Mater Chem B. 2017 Jan 21;5(3):531-536. doi: 10.1039/C6TB02787C. Epub 2016 Dec 13.

12.

Gelofusine Ameliorates Colistin-Induced Nephrotoxicity.

Sivanesan SS, Azad MAK, Schneider EK, Ahmed MU, Huang J, Wang J, Li J, Nation RL, Velkov T.

Antimicrob Agents Chemother. 2017 Nov 22;61(12). pii: e00985-17. doi: 10.1128/AAC.00985-17. Print 2017 Dec.

13.

Aminoglycoside Concentrations Required for Synergy with Carbapenems against Pseudomonas aeruginosa Determined via Mechanistic Studies and Modeling.

Yadav R, Bulitta JB, Schneider EK, Shin BS, Velkov T, Nation RL, Landersdorfer CB.

Antimicrob Agents Chemother. 2017 Nov 22;61(12). pii: e00722-17. doi: 10.1128/AAC.00722-17. Print 2017 Dec.

14.

Investigating the Interaction of Octapeptin A3 with Model Bacterial Membranes.

Han ML, Shen HH, Hansford KA, Schneider EK, Sivanesan S, Roberts KD, Thompson PE, Le Brun AP, Zhu Y, Sani MA, Separovic F, Blaskovich MAT, Baker MA, Moskowitz SM, Cooper MA, Li J, Velkov T.

ACS Infect Dis. 2017 Aug 11;3(8):606-619. doi: 10.1021/acsinfecdis.7b00065. Epub 2017 Jul 11.

15.

Hydrolyzable Poly[Poly(Ethylene Glycol) Methyl Ether Acrylate]-Colistin Prodrugs through Copper-Mediated Photoinduced Living Radical Polymerization.

Zhu C, Schneider EK, Nikolaou V, Klein T, Li J, Davis TP, Whittaker MR, Wilson P, Kempe K, Velkov T, Haddleton DM.

Bioconjug Chem. 2017 Jul 19;28(7):1916-1924. doi: 10.1021/acs.bioconjchem.7b00242. Epub 2017 Jul 7.

16.

Deficiency in outer dense fiber 1 is a marker and potential driver of idiopathic male infertility.

Hetherington L, Schneider EK, Scott C, DeKretser D, Muller CH, Hondermarck H, Velkov T, Baker MA.

Mol Cell Proteomics. 2017 Jun;16(6):1172. doi: 10.1074/mcp.A116.060343. No abstract available.

17.

Antibiotic-non-antibiotic combinations for combating extremely drug-resistant Gram-negative 'superbugs'.

Schneider EK, Reyes-Ortega F, Velkov T, Li J.

Essays Biochem. 2017 Mar 3;61(1):115-125. doi: 10.1042/EBC20160058. Print 2017 Feb 28. Review.

PMID:
28258235
18.

A traceless reversible polymeric colistin prodrug to combat multidrug-resistant (MDR) gram-negative bacteria.

Zhu C, Schneider EK, Wang J, Kempe K, Wilson P, Velkov T, Li J, Davis TP, Whittaker MR, Haddleton DM.

J Control Release. 2017 Aug 10;259:83-91. doi: 10.1016/j.jconrel.2017.02.005. Epub 2017 Feb 5.

19.

Plasma Protein Binding Structure-Activity Relationships Related to the N-Terminus of Daptomycin.

Schneider EK, Huang JX, Carbone V, Han M, Zhu Y, Nang S, Khoo KK, Mak J, Cooper MA, Li J, Velkov T.

ACS Infect Dis. 2017 Mar 10;3(3):249-258. doi: 10.1021/acsinfecdis.7b00015. Epub 2017 Feb 10.

PMID:
28142234
20.

From Breast Cancer to Antimicrobial: Combating Extremely Resistant Gram-Negative "Superbugs" Using Novel Combinations of Polymyxin B with Selective Estrogen Receptor Modulators.

Hussein MH, Schneider EK, Elliott AG, Han M, Reyes-Ortega F, Morris F, Blastovich MAT, Jasim R, Currie B, Mayo M, Baker M, Cooper MA, Li J, Velkov T.

Microb Drug Resist. 2017 Jul;23(5):640-650. doi: 10.1089/mdr.2016.0196. Epub 2016 Dec 9.

PMID:
27935770
21.

Can Cystic Fibrosis Patients Finally Catch a Breath With Lumacaftor/Ivacaftor?

Schneider EK, Reyes-Ortega F, Li J, Velkov T.

Clin Pharmacol Ther. 2017 Jan;101(1):130-141. doi: 10.1002/cpt.548. Epub 2016 Nov 23. Review.

22.

Development of HPLC and LC-MS/MS methods for the analysis of ivacaftor, its major metabolites and lumacaftor in plasma and sputum of cystic fibrosis patients treated with ORKAMBI or KALYDECO.

Schneider EK, Reyes-Ortega F, Wilson JW, Kotsimbos T, Keating D, Li J, Velkov T.

J Chromatogr B Analyt Technol Biomed Life Sci. 2016 Dec 1;1038:57-62. doi: 10.1016/j.jchromb.2016.10.026. Epub 2016 Oct 24.

23.

Deficiency in Outer Dense Fiber 1 Is a Marker and Potential Driver of Idiopathic Male Infertility.

Hetherington L, Schneider EK, Scott C, DeKretser D, Muller CH, Hondermarck H, Velkov T, Baker MA.

Mol Cell Proteomics. 2016 Dec;15(12):3685-3693. Epub 2016 Oct 21. Erratum in: Mol Cell Proteomics. 2017 Jun;16(6):1172.

24.

The Plasma Protein Binding Proteome of Ertapenem: A Novel Compound-Centric Proteomic Approach for Elucidating Drug-Plasma Protein Binding Interactions.

Baker MA, Schneider EK, X Huang J, Cooper MA, Li J, Velkov T.

ACS Chem Biol. 2016 Dec 16;11(12):3353-3364. Epub 2016 Oct 25.

PMID:
27682196
25.

A Novel Chemical Biology Approach for Mapping of Polymyxin Lipopeptide Antibody Binding Epitopes.

Velkov T, Yun B, Schneider EK, Azad MA, Dolezal O, Morris FC, Nation RL, Wang J, Chen K, Yu HH, Wang L, Thompson PE, Roberts KD, Li J.

ACS Infect Dis. 2016 May 13;2(5):341-51. doi: 10.1021/acsinfecdis.6b00031. Epub 2016 Mar 29.

26.

An "Unlikely" Pair: The Antimicrobial Synergy of Polymyxin B in Combination with the Cystic Fibrosis Transmembrane Conductance Regulator Drugs KALYDECO and ORKAMBI.

Schneider EK, Azad MA, Han ML, Tony Zhou Q, Wang J, Huang JX, Cooper MA, Doi Y, Baker MA, Bergen PJ, Muller MT, Li J, Velkov T.

ACS Infect Dis. 2016 Jul 8;2(7):478-88. doi: 10.1021/acsinfecdis.6b00035. Epub 2016 May 17.

27.

Molecular Characterisation of the Haemagglutinin Glycan-Binding Specificity of Egg-Adapted Vaccine Strains of the Pandemic 2009 H1N1 Swine Influenza A Virus.

Carbone V, Schneider EK, Rockman S, Baker M, Huang JX, Ong C, Cooper MA, Yuriev E, Li J, Velkov T.

Molecules. 2015 Jun 5;20(6):10415-34. doi: 10.3390/molecules200610415.

28.

Drug-drug plasma protein binding interactions of ivacaftor.

Schneider EK, Huang JX, Carbone V, Baker M, Azad MA, Cooper MA, Li J, Velkov T.

J Mol Recognit. 2015 Jun;28(6):339-48. doi: 10.1002/jmr.2447. Epub 2015 Feb 24.

PMID:
25707701
29.

Pain and disability under Social Security: time for a new standard.

Schneider EK, Simeone JJ.

J Health Law. 2001 Summer;34(3):459-85.

PMID:
11571895
30.

The ADA--a little used tool to remedy nursing home discrimination.

Schneider EK.

Univ Toledo Law Rev. 1997 Spring;28(3):489-519. No abstract available.

PMID:
12465635
31.

[Intraperitoneal bladder rupture].

Schülke J, Schneider EK, Theloe G.

Z Urol Nephrol. 1980 Jan;73(1):31-4. German.

PMID:
7395395
32.

Intraoral inferior border osteotomy for correction of mandibular asymmetry.

Blair AE, Schneider EK.

J Oral Surg. 1977 Jun;35(6):493-6. No abstract available.

PMID:
266065
33.

[Cytological & histological differences of bronchial carcinoma at the places of its origin & metastatic development].

SCHNEIDER EK.

Beitr Pathol Anat. 1957;118(3):339-50. German. No abstract available.

PMID:
13535532

Supplemental Content

Loading ...
Support Center